AT 1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats
- 1 May 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 37 (5), 1271-1276
- https://doi.org/10.1161/01.str.0000217404.64352.d7
Abstract
Background and Purpose— Blockade of angiotensin II AT 1 receptors in cerebral microvessels protects against brain ischemia and inflammation. In this study, we tried to clarify the presence and regulation of the local renin-angiotensin system (RAS) in brain microvessels in hypertension. Methods— Spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) controls were treated with an AT 1 receptor antagonist (candesartan, 0.3 mg/kg per day) via subcutaneous osmotic minipumps for 4 weeks. The expression and localization of RAS components and the effect of AT 1 receptor blockade were assessed by Affymetrix microarray, qRT-PCR, Western blots, immunohistochemistry and immunofluorescence. Results— We found transcripts of most of RAS components in our microarray database, and confirmed their expression by qRT-PCR. Angiotensinogen (Aogen), angiotensin-converting enzyme (ACE) and AT 1 receptors were localized to the endothelium. There was no evidence of AT 2 receptor localization in the microvascular endothelium. In SHR, (pro)renin receptor mRNA and AT 1 receptor mRNA and protein expression were higher, whereas Aogen, ACE mRNA and AT 2 receptor mRNA and protein expression were lower than in WKY rats. Candesartan treatment increased Aogen, ACE and AT 2 receptor in SHR, and increased ACE and decreased Aogen in WKY rats, without affecting the (pro)renin and AT 1 receptors. Conclusions— Increased (pro)renin and AT 1 receptor expression in SHR substantiates the importance of the local RAS overdrive in the cerebrovascular pathophysiology in hypertension. AT 1 receptor blockade and increased AT 2 receptor stimulation after administration of candesartan may contribute to the protection against brain ischemia and inflammation.Keywords
This publication has 25 references indexed in Scilit:
- High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats.Circulation, 2005
- Angiotensin II AT1 Receptor Blockade Abolishes Brain Microvascular Inflammation and Heat Shock Protein Responses in Hypertensive RatsJournal of Cerebral Blood Flow & Metabolism, 2005
- Angiotensin II AT 1 Receptor Blockade Reverses Pathological Hypertrophy and Inflammation in Brain Microvessels of Spontaneously Hypertensive RatsStroke, 2004
- AT2‐Receptor activation regulates myocardial eNOS expression via the calcineurin‐NF‐AT pathwayThe FASEB Journal, 2002
- Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT 1 AntagonistStroke, 2002
- Increased Angiotensin II AT1 Receptor Expression in Paraventricular Nucleus and Hypothalamic-Pituitary-Adrenal Axis Stimulation in AT2 Receptor Gene Disrupted MiceNeuroendocrinology, 2002
- Pre-treatment with candesartan protects from cerebral ischaemiaJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences.Hypertension, 1991
- Angiotensin‐Converting Enzyme Activity Is Reduced in Brain Microvessels of Spontaneously Hypertensive RatsJournal of Neurochemistry, 1984
- Angiotensin-Converting Enzyme: Vascular Endothelial LocalizationScience, 1976